Tienoksolol
Nazivi | |
---|---|
IUPAC naziv Etil 2-[3-(tert-butilamino)-2-hidroksipropoksi]-5-(tiofen-2-karbonilamino)benzoat | |
Identifikacija | |
| |
3D model (Jmol) |
|
ChemSpider |
|
PubChem[1][2] C ID |
|
UNII |
|
SMILES
| |
Svojstva | |
C21H28N2O5S | |
Molarna masa | 420,52 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Tienoksolol je antagonist beta adrenergičkog receptora.[3]
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Mahé, N; Do, B; Nicolaï, B; Rietveld, IB; Barrio, M; Tamarit, JL; Céolin, R; Guéchot, C; Teulon, JM (2012). „Crystal structure and solid-state studies of aged samples of tienoxolol, an API designed against hypertension”. International Journal of Pharmaceutics. 422 (1–2): 47—51. PMID 22027392. doi:10.1016/j.ijpharm.2011.10.025. hdl:2117/14578 .
- п
- р
- у
Adrenergici
|
|
|
Drugi | |||||||
---|---|---|---|---|---|---|---|
|